4//SEC Filing
Hill Stephen J. 4
Accession 0001866154-25-000005
CIK 0001806952other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:42 PM ET
Size
12.3 KB
Accession
0001866154-25-000005
Insider Transaction Report
Form 4
Hill Stephen J.
Chief Operating Officer
Transactions
- Award
Option (right to buy)
2025-10-27+75,000→ 75,000 totalExercise: $17.23Exp: 2035-10-26→ Common Stock (75,000 underlying)
Holdings
- 15,845
Common Stock
Footnotes (1)
- [F1]12.5% of the option shares will vest on April 27, 2026, with the remaining option shares to vest in equal monthly installments over the following forty-two months, subject to the reporting person providing service through the applicable vesting date.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001866154
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 5:42 PM ET
- Size
- 12.3 KB